A vs BAX: fair value comparison
Agilent Technologies, Inc. and Baxter International Inc. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, BAX currently sits closer to the top of our discount ranking. A carries the stronger quality grade.
| A | BAX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $146.93 | $23.80 |
| 12-month range | $114.52–$150.10 | $16.78–$28.10 |
| Sector rank | #57 of 113 Healthcare | #54 of 113 Healthcare |
| Quality grade | B | F |
| Leverage | Moderate | High |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Oversold |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: A fair value analysis · BAX fair value analysis